LIU Wei, GUO Miao, ZHAO Wenna, LI Wei. Levels and clinical significance of serum pyridinoline cross-linked carboxyterminal telopeptide of type Ⅰ collagen, anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with undifferentiated arthritis[J]. Journal of Clinical Medicine in Practice, 2020, 24(8): 82-85. DOI: 10.7619/jcmp.202008022
Citation: LIU Wei, GUO Miao, ZHAO Wenna, LI Wei. Levels and clinical significance of serum pyridinoline cross-linked carboxyterminal telopeptide of type Ⅰ collagen, anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with undifferentiated arthritis[J]. Journal of Clinical Medicine in Practice, 2020, 24(8): 82-85. DOI: 10.7619/jcmp.202008022

Levels and clinical significance of serum pyridinoline cross-linked carboxyterminal telopeptide of type Ⅰ collagen, anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with undifferentiated arthritis

More Information
  • Received Date: February 04, 2020
  • Objective To explore the levels of serum pyridinoline cross-linked carboxyterminal telopeptide of type Ⅰ collagen(ICTP), anti-cyclic citrullinated peptide(CCP)antibody and rheumatoid factors(RF)in patients with undifferentiated arthritis(UA). Methods Totally 60 UA patients were selected as UA group, and 32 healthy people with physical examination were selected as control group. The levels of serum ICTP, anti-CCP antibody and RF were compared between UA group and control group. The values of serum ICTP, anti-CCP antibody and RF levels in predicting the progression of UA to rheumatoid arthritis(RA)was analyzed. Results The levels of serum ICTP, anti-CCP antibody and RF in UA group were significantly higher than those in control group(P<0.05). Pearson correlation analysis showed that there was a significant positive correlation between serum ICTP and anti-CCP antibody(r=0.613, P<0.05), a significant positive correlation between serum ICTP and RF(r=0.438, P<0.05), and a significant positive correlation between serum anti-CCP antibody and RF(r=0.452, P<0.05). The results of Receiver Operating Characteristic - (ROC)curve analysis showed that the best cut-off values of ICTP, anti-CCP antibody and RF in predicting the progression of UA to RA were 4.52 μg/L, 20.84 U/mL and 18.50 U/mL respectively. The area under the curve(AUC)predicted by combination of serum ICTP, anti-CCP antibody and RF levels was significantly higher than that by RF(Z=2.573, P=0.010). Conclusion The levels of serum ICTP, anti-CCP antibody and RF have certain values in predicting the progression of UA to RA, and the combined detection of the three indexes shows great significance for the early prediction of the outcome of UA.
  • 吴佳丽, 吴斌, 李延萍. 未分化关节炎的研究概况[J]. 风湿病与关节炎, 2017, 6(6): 66-70.
    Olivieri I, Sarzi-Puttini P, Bugatti S, et al. Early treatment in early undifferentiated arthritis[J]. Autoimmun Rev, 2012, 11(8): 589-592.
    李姝玉, 朱琦, 姜婷, 等. Ⅰ型胶原吡啶交联末端肽在评价类风湿关节炎患者病情活动和骨丢失中的临床意义[J]. 中国骨质疏松杂志, 2012, 18(3): 248-251

    , 254.
    关晓东, 吴宇芳, 陈少莹, 等. 联合检测ICTP、抗CCP抗体和RF在未分化关节炎向类风湿关节炎转化的预测价值[J]. 重庆医学, 2015, 44(34): 4787-4789.
    高占珍, 武华, 侯胜利, 等. 抗CCP、dsDNA、ssDNA抗体对未分化关节炎转归为RA和SLE的意义[J]. 现代免疫学, 2014, 34(2): 136-139.
    Aletaha D, Neogi T, Silman A J, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581.
    McNally E, Keogh C, Galvin R, et al. Diagnostic accuracy of a clinical prediction rule(CPR)for identifying patients with recent-onset undifferentiated arthritis who are at a high risk of developing rheumatoid arthritis: a systematic review and meta-analysis[J]. Semin Arthritis Rheum, 2014, 43(4): 498-507.
    van der Helm-van Mil A H, Detert J, le Cessie S, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making[J]. Arthritis Rheum, 2008, 58(8): 2241-2247.
    Lopez-Olivo M A, Kakpovbia-Eshareturi V, des Bordes J K, et al. Treating early undifferentiated arthritis: a systematic review and meta-analysis of direct and indirect trial evidence[J]. Arthritis Care Res(Hoboken), 2018, 70(9): 1355-1365.
    李玉翠, 范文强, 陈海英, 等. 2012年早期类风湿关节炎分类标准的国内多中心临床验证[J]. 中华风湿病学杂志, 2017, 21(12): 807-811.
    Bizzaro N, Bartoloni E, Morozzi G, et al. Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study[J]. Arthritis Res Ther, 2013, 15(1): R16-R23.
    Fardellone P, Sejourne A, Paccou J, et al. Bone remodelling markers in rheumatoid arthritis[J]. Mediators Inflamm, 2014, 2014: 484280-484288.
    陈竹, 杨宇峰, 王彩虹, 等. 自身抗体阳性的未分化关节炎向类风湿关节炎转化的预测价值[J]. 中华风湿病学杂志, 2009, 13(11): 749-753.
    张志田, 闻建民, 郦妙尔, 等. 动态增强MRI在MTX阻断治疗早期未分化关节炎中的应用价值[J]. 医学影像学杂志, 2015, 25(10): 1868-1870.
    王园园, 赵令, 马红爽, 等. 类风湿因子在原发性干燥综合征不同临床表现中的意义[J]. 中国免疫学杂志, 2016, 32(11): 1641-1644.
    罗德梅, 李文红, 王倩, 等. Ⅱ型胶原诱导性关节炎大鼠血清抗角蛋白抗体和抗环瓜氨酸肽抗体及类风湿因子的检测分析[J]. 中国全科医学, 2016, 19(27): 3287-3290.
    陶蕾, 薛建峰, 翟乾勋, 等. 抗环瓜氨酸肽抗体联合类风湿因子对老年类风湿关节炎的诊断价值分析[J]. 中国生化药物杂志, 2015, 35(3): 103-105.
    孙兴, 李茹, 李玉翠等. 免疫球蛋白G型类风湿因子在类风湿关节炎诊断和预后判断中的意义[J]. 中华风湿病学杂志, 2018, 22(4): 220-223.
    郑建琼, 周发为, 杨年安, 等. 白细胞介素-17及类风湿因子联合检测在老年类风湿关节炎诊断中的应用[J]. 中国老年学杂志, 2015, 35(9): 2486-2488.
    李小月, 査勇, 霍佩珍, 等. 抗环瓜氨酸肽-CCP抗体及类风湿因子对类风湿关节炎的临床意义[J]. 中国实验诊断学, 2015, 19(4): 570-572.
    和雅, 史丽璞, 韩丹, 等. 三种自身抗体检测对未分化关节炎向类风湿关节炎转化的预测价值[J]. 中国医药指南, 2012, 10(11): 117-118.
    董奕裕, 张新根, 陆建良, 等. Ⅰ型胶原吡啶交联终肽等项目对于早期类风湿关节炎患者的预测价值[J]. 中国卫生检验杂志, 2013, 23(6): 1532-1534.
    李虎才. 血清Ⅰ型胶原吡啶交联终肽、滑膜厚度等项目在早期类风湿关节炎诊断及疗效监测的应用[D]. 南昌: 南昌大学, 2016.
    吴宇芳, 关晓东, 陈少莹, 等. 联合检测ICTP和抗CCP抗体对类风湿关节炎早期诊断的意义[J]. 现代预防医学, 2015, 42(16): 3069-3072.
    高利霞. 抗CCP抗体、抗RA33抗体及RF联合检测对类风湿关节炎的临床诊断价值[J]. 山西医科大学学报, 2014, 45(2): 116-118.
    陈晓宇. 血清RF、抗CCP抗体和AFA抗体联合检测在早期诊断类风湿关节炎中的价值[J]. 中国现代医生, 2018, 56(32): 1-4.
  • Related Articles

    [1]CHEN Chen, LI Yufu, KONG Lingshuang, AN Xiaobei. Efficacy of Qizhu Bishi Granules combined with methotrexate in treatment of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2024, 28(24): 88-92. DOI: 10.7619/jcmp.20242783
    [2]LIN Jie, GAO Huiguang,, ZHANG Li. Application values of anti-cyclic citrullinated peptideantibody and anti-keratin antibody detections in the diagnosis of rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 110-111,115. DOI: 10.7619/jcmp.201915030
    [3]MA Yinghui, DAI Hao, LI Zhi, WANG Lingchun, MAO Jianying, LU Lingling, ZHAI Weitao. Relationship between rheumatoid arthritis flatfoot and flexor pollicis longus tendon lesion[J]. Journal of Clinical Medicine in Practice, 2017, (21): 68-70. DOI: 10.7619/jcmp.201721020
    [4]RUAN Qiang, JANG Mingxiao, YANG Bofeng, LU Meng, YAO Wenping, YANG Li. Effect of bee-needle therapy on treatment of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2017, (5): 68-71. DOI: 10.7619/jcmp.201705019
    [5]FU Bensheng, QIAO Jinlin, DING Yu, NIU Lufang. Efficacy and safety of cervus and cucumis polypeptide on treatment of patients with rheumatoid arthritis in active stage[J]. Journal of Clinical Medicine in Practice, 2015, (21): 52-55. DOI: 10.7619/jcmp.201521014
    [6]SHEN Ting, WAN Binbin. Influence of health education on the treatment compliance and pain of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2015, (6): 30-32,42. DOI: 10.7619/jcmp.201506010
    [7]The expression and significance of serum cytokines in elderly patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2014, (13): 26-28,32. DOI: 10.7619/jcmp.201413009
    [8]YAO Chaoqiong. Curative effect of type Ⅱ human recombinant of tumor necrosis factor receptor antibody fusion protein in the treatment of rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2013, (16): 12-14. DOI: 10.7619/jcmp.201316005
    [9]HUANG Wenhui, CHEN Ruilin, ZENG Yingyu, LIN Zeying. Changes and significance of interleukin-33,tumor necrosis factor-αand C reaction protein levels in patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2013, (15): 5-7. DOI: 10.7619/jcmp.201315002
    [10]MIAO Jin. Diagnostic values of combined determination of serum rheumatoid factor, antikeratin antibody,C reaction protein and anti-CCP antibody in patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2012, (21): 124-125,128.

Catalog

    Article views (275) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return